This hypothesis is supported by a similar study showing that treatment of diet-induced obese mice with a small-molecule inhibitor of SHIP1, K118, improves blood glucose tolerance and insulin sensitivity, and reverses diet-associated obesity by attenuating inflammation in the visceral adipose tissue 67. Here, INPP5D is linked to obesity due to melanocortin 4 receptor deficiency.